세계의 의약품용 젤라틴 시장 규모는 2023년에 11억 달러로 평가되며, 2024년 11억 6,000만 달러에서 2032년에는 17억 5,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 5.3%로 성장할 전망입니다.
세계 제약용 젤라틴 시장은 노인 인구 증가와 만성질환의 유병률 증가에 힘입어 캡슐 및 젤라틴 기반 의약품에 대한 수요가 증가함에 따라 성장할 것으로 예측됩니다. 바이오의약품과 백신 개발이 급증하면서 시장 잠재력이 더욱 커지고 있습니다. 소프트젤과 하드 캡슐 제제의 인기는 소비자들이 복용하기 쉬운 복용법을 찾고 있다는 점에서 젤라틴의 필수적인 역할을 지원하고 있습니다. 또한 특히 건강 지향적 시장으로 확대되고 있는 건강보조식품 부문도 이러한 추세에 긍정적으로 기여하고 있습니다. 그러나 시장은 동물성 젤라틴에 대한 우려와 식단 및 종교적 제한 등의 문제로 인해 식물성 대체품으로의 전환을 촉구하고 있습니다. 이러한 요인은 특정 지역에서는 광범위한 전략에 방해가 될 수 있지만, 업계 내에서는 기술 혁신의 기회가 될 수 있습니다.
Global Pharmaceutical Gelatin Market size was valued at USD 1.1 billion in 2023 and is poised to grow from USD 1.16 billion in 2024 to USD 1.75 billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032).
The global pharmaceutical gelatin market is poised for growth driven by an increasing demand for capsule and gelatin-based medications, fueled by a growing geriatric population and the rising prevalence of chronic diseases. The surge in biopharmaceuticals and vaccine development further enhances market potential. The popularity of soft gel and hard capsule formulations underscores the integral role of gelatin, as consumers seek easy-to-consume options for medication. Additionally, the expanding nutraceutical sector, particularly in health-conscious markets, contributes positively to this trend. However, the market faces challenges from concerns regarding animal-derived gelatin, along with dietary and religious restrictions, prompting a shift toward plant-based alternatives. Although these factors may hinder broader strategies in certain regions, they provide opportunities for innovation within the industry.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Gelatin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Gelatin Market Segments Analysis
Global Pharmaceutical Gelatin Market is segmented by Product Type, Application, Source, End-User and region. Based on Product Type, the market is segmented into Type A and Type B. Based on Application, the market is segmented into Capsules, Tablets, Suppositories and Vaccines. Based on Source, the market is segmented into Porcine, Bovine and Fish. Based on End-User, the market is segmented into Pharmaceuticals, Nutraceuticals and Cosmetics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Gelatin Market
The increasing demand for pharmaceutical products in capsule form is significantly fueling the Global Pharmaceutical Gelatin market. Gelatin capsules offer advantages such as ease of swallowing and enhanced bioavailability, making them a vital component in both prescription and over-the-counter medications. This growing interest among consumers and healthcare providers underscores the importance of gelatin in the pharmaceutical industry, leading to consistent and robust market growth. The versatility and functional benefits of gelatin capsules continue to contribute to their popularity, further solidifying their role in the development of innovative drug delivery systems across various therapeutic areas.
Restraints in the Global Pharmaceutical Gelatin Market
The rising inclination towards vegan, vegetarian, and plant-based lifestyles has significantly shifted consumer preferences towards non-animal gelatin alternatives. This trend is particularly evident in the nutraceutical and dietary supplement sectors, where the demand for plant-based capsules is gaining traction. Consequently, traditional gelatin products face growing competition, especially in markets where health-consciousness and vegan considerations are paramount. This shift poses a challenge for manufacturers of animal-derived gelatin, as they must adapt to the changing landscape and address the needs of consumers who prioritize ethical and health-related factors in their purchasing decisions.
Market Trends of the Global Pharmaceutical Gelatin Market
The global pharmaceutical gelatin market is witnessing significant growth driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular issues, and arthritis, which necessitate consistent medication solutions. The demand for patient-friendly drug delivery formats, particularly gelatin capsules and soft gel capsules, is rising due to their ease of administration and precise dosing. This preference for convenient and effective medication delivery is propelling the expansion of the pharmaceutical gelatin market across various therapeutic segments. As healthcare providers seek innovative ways to enhance patient compliance and treatment outcomes, the versatility and functionality of gelatin in pharmaceuticals continue to bolster market potential.